StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday
Mesoblast reports Q1 net cash from / (used in) operating activities ($14.9M) - Appendix 4C (A$2.62, 0.00)
Mesoblast reports Ryoncil September quarter gross revenues $21.9M, +66% q/q (A$2.59, 0.00)
Powered by FactSet Research Systems Inc.